With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

Last year, global sales for Wegovy stood at $8 billion, while Ozempic, the same drug but officially approved for type 2 diabetes, amounted to $17 billion. With a deeply embedded presence in the ...

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.

And it is leaving women like me more confused than ever. I’m very much someone who thinks “each to their own, you do you” – but there is an effect on those of us not taking Ozempic. I’ve ...

More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment.

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in people with obesity or overweight and a weight-related health condition. It ...

How to Inject Wegovy Pen: A Step-by-Step Guide This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the taste of meat.

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma’s “next generation” weight loss drug.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why NVO stock is a hold.

WE’VE heard celebrities talk about the positives of Ozempic and other fat loss jabs – but there’s also a host of nasty side effects they may cause. The likes of Gemma Collins and … ...